|
NPTN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62581059726108E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63768998362457E-12 |
| Normal-vs-Stage2 |
3.33979954802999E-10 |
| Normal-vs-Stage3 |
6.228300097888E-10 |
| Normal-vs-Stage4 |
1.8740699999964E-05 |
| Stage1-vs-Stage2 |
9.607200E-01 |
| Stage1-vs-Stage3 |
7.969800E-01 |
| Stage1-vs-Stage4 |
8.270400E-01 |
| Stage2-vs-Stage3 |
8.436600E-01 |
| Stage2-vs-Stage4 |
8.681800E-01 |
| Stage3-vs-Stage4 |
9.572600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64901425847575E-12 |
| Normal-vs-AfricanAmerican |
4.98490138056695E-11 |
| Normal-vs-Asian |
3.54300000000585E-05 |
| Caucasian-vs-AfricanAmerican |
4.475800E-01 |
| Caucasian-vs-Asian |
7.785600E-01 |
| AfricanAmerican-vs-Asian |
5.569600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.09709999973617E-08 |
| Male-vs-Female |
3.781600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.40199996057078E-09 |
| Normal-vs-Extreme_Weight |
1.99107397236276E-12 |
| Normal-vs-Obese |
1.4342005361101E-10 |
| Normal-vs-Extreme_Obese |
6.43730000415843E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.480600E-01 |
| Normal_Weight-vs-Obese |
6.496800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.038400E-01 |
| Extreme_Weight-vs-Obese |
1.451370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.639200E-01 |
| Obese-vs-Extreme_Obese |
2.716600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.8407999548038E-09 |
| Normal-vs-Age(41-60Yrs) |
9.67270707974421E-12 |
| Normal-vs-Age(61-80Yrs) |
4.13002965160558E-14 |
| Normal-vs-Age(81-100Yrs) |
4.60970039917186E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.128800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.496200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.937820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.248150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.481900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.032440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
7.1276318180935E-14 |
| Normal-VS-KIRP CIMP |
9.73389999999741E-05 |
| Normal-VS-Unclassified PRCC |
1.5422999988246E-08 |
| Type1 PRCC-VS-Type2 PRCC |
9.141600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.336000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.424300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.069800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.443170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.543600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7715611723761E-16 |
| Normal-vs-N1 |
4.50270043472756E-10 |
| Normal-vs-N2 |
6.398100E-03 |
| N0-vs-N1 |
4.314600E-01 |
| N0-vs-N2 |
6.917000E-01 |
| N1-vs-N2 |
8.265600E-01 |
|
|
